Works by Cha, Bong‐Soo

Results: 78
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1869, doi. 10.1111/dom.14085
    By:
    • Kim, Sin Gon;
    • Kim, Kyoung Jin;
    • Yoon, Kun Ho;
    • Chun, Sung Wan;
    • Park, Kyong Soo;
    • Choi, Kyung Mook;
    • Lim, Soo;
    • Mok, Ji‐Oh;
    • Lee, Hyoung Woo;
    • Seo, Ji A.;
    • Cha, Bong‐Soo;
    • Kim, Mi Kyung;
    • Shon, Ho Sang;
    • Choi, Dong Seop;
    • Kim, Doo Man
    Publication type:
    Article
    10

    Cover Image, Volume 21, Issue 4.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. i, doi. 10.1111/dom.13688
    By:
    • Kim, Jin Hee;
    • Lee, Minyoung;
    • Kim, Soo Hyun;
    • Kim, So Ra;
    • Lee, Byung‐Wan;
    • Kang, Eun Seok;
    • Cha, Bong‐Soo;
    • Cho, Jin Won;
    • Lee, Yong‐ho
    Publication type:
    Article
    11
    12
    13

    Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2408, doi. 10.1111/dom.13394
    By:
    • Han, Kyung‐ah;
    • Chon, Suk;
    • Chung, Choon Hee;
    • Lim, Soo;
    • Lee, Kwan‐woo;
    • Baik, Seihyun;
    • Jung, Chang Hee;
    • Kim, Dong‐sun;
    • Park, Kyong Soo;
    • Yoon, Kun‐ho;
    • Lee, In‐kyu;
    • Cha, Bong‐soo;
    • Sakatani, Taishi;
    • Park, Sumi;
    • Lee, Moon‐kyu
    Publication type:
    Article
    14
    15
    16
    17
    18

    Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.

    Published in:
    Journal of Diabetes Investigation, 2014, v. 5, n. 6, p. 701, doi. 10.1111/jdi.12201
    By:
    • Kim, Hye‐soon;
    • Kim, Doo‐man;
    • Cha, Bong‐soo;
    • Park, Tae Sun;
    • Kim, Kyoung‐ah;
    • Kim, Dong‐lim;
    • Chung, Choon Hee;
    • Park, Jeong‐hyun;
    • Jang, Hak Chul;
    • Choi, Dong‐seop
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

    Published in:
    Clinical Endocrinology, 2007, v. 66, n. 2, p. 282, doi. 10.1111/j.1365-2265.2006.02723.x
    By:
    • Kim, Hyeong Jin;
    • Kang, Eun Seok;
    • Kim, Dae Jung;
    • Kim, So Hun;
    • Ahn, Chul Woo;
    • Cha, Bong Soo;
    • Nam, Moonsuk;
    • Chung, Choon Hee;
    • Lee, Kwan Woo;
    • Nam, Chung Mo;
    • Lee, Hyun Chul
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50